170 related articles for article (PubMed ID: 35862385)
1. High prevalence of p16 staining in malignant tumors.
De Wispelaere N; Rico SD; Bauer M; Luebke AM; Kluth M; Büscheck F; Hube-Magg C; Höflmayer D; Gorbokon N; Weidemann S; Möller K; Fraune C; Bernreuther C; Simon R; Kähler C; Menz A; Hinsch A; Jacobsen F; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Steurer S; Burandt E; Krech R; Dum D; Krech T; Marx A; Minner S
PLoS One; 2022; 17(7):e0262877. PubMed ID: 35862385
[TBL] [Abstract][Full Text] [Related]
2. p16 expression in urothelial carcinoma: Experience from a tertiary care center in coastal South India.
Sachdeva S; Suresh PK; Basavaiah SH; Sahu KK; Sreeram S; Kini H; Kini JR; Pinto AC
J Cancer Res Ther; 2023; 19(5):1330-1334. PubMed ID: 37787303
[TBL] [Abstract][Full Text] [Related]
3. Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection.
Blochin EB; Park KJ; Tickoo SK; Reuter VE; Al-Ahmadie H
Mod Pathol; 2012 Nov; 25(11):1534-42. PubMed ID: 22766788
[TBL] [Abstract][Full Text] [Related]
4. Application of p16 Immunohistochemistry and RNA In Situ Hybridization in the Classification of Adenoid Basal Tumors of the Cervix.
Goyal A; Wang Z; Przybycin CG; Yang B
Int J Gynecol Pathol; 2016 Jan; 35(1):82-91. PubMed ID: 26352551
[TBL] [Abstract][Full Text] [Related]
5. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
[TBL] [Abstract][Full Text] [Related]
6. Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival.
Wittekindt C; Gültekin E; Weissenborn SJ; Dienes HP; Pfister HJ; Klussmann JP
Adv Otorhinolaryngol; 2005; 62():72-80. PubMed ID: 15608419
[TBL] [Abstract][Full Text] [Related]
7. Detection of human papillomavirus DNA and expression of p16, Rb, and p53 proteins in small cell carcinomas of the uterine cervix.
Wang HL; Lu DW
Am J Surg Pathol; 2004 Jul; 28(7):901-8. PubMed ID: 15223960
[TBL] [Abstract][Full Text] [Related]
8. Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors.
Schallenberg S; Plage H; Hofbauer S; Furlano K; Weinberger S; Bruch PG; Roßner F; Elezkurtaj S; Kluth M; Lennartz M; Blessin NC; Marx AH; Samtleben H; Fisch M; Rink M; Slojewski M; Kaczmarek K; Ecke T; Hallmann S; Koch S; Adamini N; Minner S; Simon R; Sauter G; Horst D; Klatte T; Schlomm T; Zecha H
Acta Oncol; 2023 Dec; 62(12):1880-1889. PubMed ID: 37938166
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva.
Santos M; Montagut C; Mellado B; García A; Ramón y Cajal S; Cardesa A; Puig-Tintoré LM; Ordi J
Int J Gynecol Pathol; 2004 Jul; 23(3):206-14. PubMed ID: 15213596
[TBL] [Abstract][Full Text] [Related]
10. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias.
Riethdorf S; Neffen EF; Cviko A; Löning T; Crum CP; Riethdorf L
Hum Pathol; 2004 Dec; 35(12):1477-83. PubMed ID: 15619206
[TBL] [Abstract][Full Text] [Related]
11. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
Lu DW; El-Mofty SK; Wang HL
Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
[TBL] [Abstract][Full Text] [Related]
12. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia.
Keating JT; Cviko A; Riethdorf S; Riethdorf L; Quade BJ; Sun D; Duensing S; Sheets EE; Munger K; Crum CP
Am J Surg Pathol; 2001 Jul; 25(7):884-91. PubMed ID: 11420459
[TBL] [Abstract][Full Text] [Related]
13. p16(INK4a) overexpression is not linked to oncogenic human papillomaviruses in patients with high-grade urothelial cancer cells.
Piaton E; Casalegno JS; Advenier AS; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A; Mekki Y
Cancer Cytopathol; 2014 Oct; 122(10):760-9. PubMed ID: 25069600
[TBL] [Abstract][Full Text] [Related]
14. Time trends in prevalence of p16 positivity and combined HPV/p16 positivity in a large cohort of Danish vulvar cancer patients.
Rasmussen CL; Thomsen LT; Baandrup L; Franzmann MB; Kjaer AK; Larsen LG; Madsen EM; Salinas NMV; Schledermann D; Winberg BH; Ørnskov D; Waldstrøm M; Kjaer SK
Int J Cancer; 2023 Jun; 152(11):2424-2432. PubMed ID: 36694992
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of high-risk human papillomavirus in primary squamous cell carcinoma of urinary bladder.
Collins K; Hwang M; Hamza A; Rao P
Pathol Res Pract; 2020 Sep; 216(9):153084. PubMed ID: 32825952
[TBL] [Abstract][Full Text] [Related]
16. The role of human papillomavirus in p16-positive oral cancers.
Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M
J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035
[TBL] [Abstract][Full Text] [Related]
17. p16 overexpression in high-grade neuroendocrine carcinomas of the head and neck: potential diagnostic pitfall with HPV-related carcinomas.
Alos L; Hakim S; Larque AB; de la Oliva J; Rodriguez-Carunchio L; Caballero M; Nadal A; Marti C; Guimera N; Fernandez-Figueras MT; Quint W; Ordi J
Virchows Arch; 2016 Sep; 469(3):277-84. PubMed ID: 27392929
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
19. p16 immunostaining in cytology specimens: its application, expression, interpretation, and challenges.
Ribeiro EA; Maleki Z
J Am Soc Cytopathol; 2021; 10(4):414-422. PubMed ID: 33422456
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]